omniture
信念医药

Latest News

Belief BioMed to Collaborate with AskBio to Explore the Potential of New Gene Therapies

* Belief BioMed and AskBio will work together to advance potential gene therapies in diseases wit...

2024-09-25 14:58 1451

Belief BioMed Successfully Completed Dosing of First Subject in the Registrational Clinical Trial for Hemophilia A

SHANGHAI, Jan. 3, 2024 /PRNewswire/ -- Belief BioMed Group (BBM), an industry-leading biotech compa...

2024-01-03 18:10 1979

Belief BioMed Announces a Key Milestone of Dosing Completion for All Subjects in its Registrational Clinical Trial of BBM-H901

SHANGHAI, April 24, 2023 /PRNewswire/ -- Belief BioMed Group (BBM), an industry-leading biotech com...

2023-04-24 10:23 2444

Clinical trial results of Belief BioMed's hemophilia B gene therapy drug candidate BBM-H901 published in The Lancet Haematology

SHANGHAI, May 20, 2022 /PRNewswire/ -- The early phase clinical trial results of BBM-H901, the firs...

2022-05-20 10:43 4394

Belief Biomed's Gene Therapy for Hemophilia B Receives NMPA IND Approval: First Intravenous Infusion Gene Therapy for Rare Disease in China

SHANGHAI, Aug. 10, 2021 /PRNewswire/ -- On August 10th, 2021,Belief Biomed announced thatChina's Na...

2021-08-10 23:39 1578